| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | CEO, Director | $2.06M | May 1, 2025 | ||
| ALDX | Aldeyra Therapeutics, Inc. | Director | Jun 10, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|